NEW YORK (AVAFIN) -- Financial institutions traded 14 block trades on shares of Valeant Pharmaceuticals International. Further analysis into the trading activity revealed that 117,850 shares were bought and 143,250 shares were sold. The bought/sold ratio for shares of VRX is 0.82, representing a negative net cash flow of $3,117,436 out of the stock.
On the options side, investors traded a total of 12,890 contracts. Specifically, 5,772 call and 7,118 put contracts were traded yesterday yielding a 1.23 put/call ratio.
Valeant Pharmaceuticals International is a specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.
Valeant Pharmaceuticals International settled the day up $2.26 to $121.71 in the previous trading session. Today's trading range was between $118.93 and $122.07 respectively. On the volume side, 2.97M shares were traded, which is greater than the average volume of 2.87M shares. VRX is trading below the 50 day moving average and lower than the 200 day moving average. The stock's 52 week low is $89.76 and 52 week high is $153.10. Within the last week, the shares have lost -2.23% of their value.
-
Company DirectoryFreight RateExport RateAgency PartnershipCargo Leads